Sachin Shah, MD
Interventional Pain Medicine · Somerset, NJNPI 1265665228
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,626 of the $3,856 with a category attached, or 68.1%. 17 manufacturers reported payments, led by Medtronic at 54.8% of the total. Reporting peaked in 2021 at $1,982 and has fallen 91.6% since, to $167 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in NJ, where the typical reported total is $3,760.
Across 124 payments — averaging $31.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$679
- Biotronik NRO, Inc.$319
- Nevro Corp.$226
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$111
- Collegium Pharmaceutical, Inc.$86
- plus $324 from 11 others
What the payments were for
- Speaking & faculty fees$1,23032%
- Food & beverage$2,62668%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 47 | $2,111 |
| Boston Scientific | 21 | $679 |
| Biotronik NRO, Inc. | 21 | $319 |
| Nevro Corp. | 5 | $226 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $111 |
| Collegium Pharmaceutical, Inc. | 6 | $86 |
| Nalu Medical, Inc. | 3 | $69 |
| Protega Pharmaceutials Inc | 3 | $49 |
| Arteriocyte Medical Systems, Inc. | 1 | $45 |
| Kowa Pharmaceuticals America, Inc. | 3 | $43 |
| Ossur Americas, Inc. | 1 | $26 |
| Si-bone, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Vertos Medical, Inc. | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,856 in reported general payments places this provider in the 50th percentile of 82 interventional pain medicine providers in New Jersey.
See all interventional pain medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 30 | $19,619 |
| OxycontinOxycodone Hcl | 14 | $14,720 |
| Fentanyl | 24 | $4,935 |
| Oxycodone Hcl | 262 | $4,544 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 206 | $4,021 |
| Morphine Sulfate ErMorphine Sulfate | 40 | $1,344 |
| Gabapentin | 107 | $1,121 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $1,001 |
| Duloxetine Hcl | 19 | $672 |
| Tizanidine Hcl | 62 | $570 |
| Morphine Sulfate | 22 | $546 |
| Tramadol Hcl | 125 | $521 |
| Methadone Hcl | 37 | $513 |
| Pregabalin | 31 | $470 |
| Diclofenac Sodium | 13 | $319 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $86 | $19,61930 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 82 interventional pain medicine providers in New Jersey.
Other interventional pain medicine in Somerset
- Didier DemesminSomerset$33K
- Brendan O'DonovanSomerset$4K
- Catvan leSomerset$3K
- Youssef JosephsonWest Deptford$496K
- Ali ValimahomedHolmdel$415K
- Saurabh DangEdgewater$157K
- Gabriele JasperBrick$114K
- Matthew LippChatham$67K
- Steve AydinFranklin Lakes$22K
- Kieran SlevinHainesport$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.